ArticleInvestigational new drugs2015

Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies.

Amit Mahipal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.